Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies

Biointron 2024-11-04

Authors: Yizhou Zhang,Ruicheng Wei,Ge Song,Xinyi Yang,Mengli Zhang,Wei Liu,Aiying Xiong,Xuehan Zhang,Qianhao Li,Wan-Jen Yang,Chencheng Han,Rui Liu,Chen Hu,Qingyu Wang,Jun Zhu & Yongqiang Shan

Journal: Mabs

PubMed ID: 39497266

DOI: https://doi.org/10.1080/19420862.2024.2419838

Products & Services: B2014, B6924

Subscribe to our Citations Database

Recommended Articles

MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma

MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IR……

Nov 25, 2025

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybri……

Aug 07, 2025

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of ……

Aug 01, 2025

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatmen……

Jul 30, 2025